GREAT POINT PARTNERS LLC
CIK 1281446 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $529.1M
- Posisi
- 42
- Per tanggal
- 30 Juni 2026
#3.641 dari 9.443 berdasarkan nilai 13F · top 38.6%
Nilai portofolio QoQ: +21.6% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 51,64%
- Bobot 25 kepemilikan teratas
- 87,13%
- Posisi di atas 1%
- 29
- Jumlah posisi efektif
- 25,0
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 36,83% Perkiraan pembelian $220.513.611 · penjualan $177.562.975
Kepemilikan median: 2,0 kuartal Dilacak Q4 2024–Q2 2026 · 44,7% masih dipegang
- Posisi baru
- 13
- Meningkat
- 7
- Menurun
- 9
- Tertutup
- 13
Eksposur put-notional: 8,8% put 13F melaporkan posisi opsi pada nilai notional yang mendasarinya — dapat mencakup lindung nilai, tidak selalu taruhan bearish
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +92.3% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 96,6% · Opsi dikecualikan: 2,2%
Rincian sektor
Healthcare
93,5%
Lainnya/Tidak terpetakan
6,5%
Portofolio lengkap 42 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| ABVX Abivax SA - American Depositary Shares | $53.304.000 | 10,07% | 400.000 | Opsi beli | Naik ×1 | ||
| VOR Vor Biopharma Inc. - Common Stock | $31.297.000 | 5,91% | 1.700.000 | $77.000 | Turun ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $27.226.884 | 5,15% | 204.314 | ||||
| IBRX ImmunityBio, Inc. - Common Stock | $26.272.004 | 4,97% | 3.000.800 | Opsi jual | $3.255.868 | ||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $25.781.873 | 4,87% | 600.836 | $17.762.103 | Naik ×1 | ||
| ZURA Zura Bio Limited - Class A Ordinary shares | $24.873.987 | 4,70% | 4.215.930 | $-210.797 | |||
| ALMS Alumis Inc. - Common Stock | $24.089.557 | 4,55% | 856.061 | $5.230.533 | |||
| SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | $20.341.273 | 3,84% | 274.363 | $-1.393.764 | |||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $20.034.000 | 3,79% | 600.000 | Opsi jual | Naik ×1 | ||
| DFTX Definium Therapeutics, Inc. - Common Shares | $19.992.000 | 3,78% | 425.000 | Naik ×1 | |||
| ANNX Annexon, Inc. - common stock | $19.985.000 | 3,78% | 3.500.000 | $6.135.000 | Naik ×1 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $17.447.516 | 3,30% | 183.330 | $8.455.179 | |||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $16.662.679 | 3,15% | 855.813 | $7.342.679 | Naik ×1 | ||
| SGMT Sagimet Biosciences Inc. - Series A Common Stock | $15.691.382 | 2,97% | 2.029.933 | Naik ×1 | |||
| CTNM Contineum Therapeutics, Inc. - Common stock | $15.103.074 | 2,85% | 921.481 | $4.652.488 | Naik ×2 | ||
| IMMX Immix Biopharma, Inc. - Common Stock | $13.172.489 | 2,49% | 1.277.642 | $9.983.989 | Naik ×1 | ||
| CLYM Climb Bio, Inc. - Common Stock | $13.040.000 | 2,46% | 1.000.000 | $3.901.209 | Turun ×1 | ||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $12.572.000 | 2,38% | 700.000 | $-11.753.000 | Turun ×1 | ||
| NKTR Nektar Therapeutics - Common Stock | $12.216.750 | 2,31% | 175.000 | $-10.552.043 | Turun ×1 | ||
| NGNE Neurogene Inc. - Common Stock | $11.076.061 | 2,09% | 352.180 | $996.061 | Turun ×1 | ||
| LBRX LB Pharmaceuticals Inc - Common Stock | $10.295.408 | 1,95% | 317.221 | $2.897.408 | Naik ×1 | ||
| IRD Opus Genetics, Inc. - Common Stock | $8.097.469 | 1,53% | 1.970.187 | $6.621.722 | Naik ×1 | ||
| EPRX Eupraxia Pharmaceuticals Inc. - Common Stock | $7.932.000 | 1,50% | 1.200.000 | $-756.000 | |||
| DRUG Bright Minds Biosciences Inc. - common stock | $7.694.131 | 1,45% | 109.603 | $-8.359.269 | Turun ×1 | ||
| IFRX InflaRx N.V. - Common Stock | $6.824.288 | 1,29% | 3.046.557 | Naik ×1 | |||
| RLMD Relmada Therapeutics, Inc. - Common Stock | $5.827.374 | 1,10% | 842.106 | $-33.684 | |||
| Penerbit tidak dikenal (CUSIP: G50765109) | $5.680.000 | 1,07% | 500.000 | Naik ×1 | |||
| CGEM Cullinan Therapeutics, Inc. - Common Stock | $5.463.000 | 1,03% | 300.000 | $1.200.000 | |||
| ALT Altimmune, Inc. - Common Stock | $5.293.345 | 1,00% | 1.741.232 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: G0375M101) | $5.080.000 | 0,96% | 500.000 | Naik ×1 | |||
| RZLT Rezolute, Inc. - Common Stock (NV) | $4.949.407 | 0,94% | 951.809 | $2.046.390 | |||
| SLN Silence Therapeutics Plc - American Depository Share | $4.941.000 | 0,93% | 450.000 | $-436.977 | Turun ×1 | ||
| PALI Palisade Bio, Inc. - Common Stock | $4.775.272 | 0,90% | 2.284.819 | $-1.184.803 | Turun ×1 | ||
| EVMN Evommune, Inc. Common Stock | $4.319.250 | 0,82% | 325.000 | $-3.152.500 | |||
| Penerbit tidak dikenal (CUSIP: 811292309) | $3.843.268 | 0,73% | 944.292 | Naik ×1 | |||
| GALT Galectin Therapeutics Inc. - Common Stock | $3.712.000 | 0,70% | 800.000 | Opsi beli | $1.480.000 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $3.552.500 | 0,67% | 70.000 | Naik ×1 | |||
| HUMA Humacyte, Inc. - Common Stock | $2.926.500 | 0,55% | 3.750.000 | $651.375 | |||
| RNTX Rein Therapeutics, Inc. - Common Stock | $2.678.000 | 0,51% | 2.575.000 | Naik ×1 | |||
| DBVT DBV Technologies S.A. - American Depositary Shares | $2.573.258 | 0,49% | 156.906 | ||||
| AVXL Anavex Life Sciences Corp. - Common Stock | $1.350.167 | 0,26% | 521.300 | Opsi beli | $-250.224 | ||
| PMN ProMIS Neurosciences Inc. - Common Shares | $1.133.734 | 0,21% | 86.150 | $-3.583.071 | Turun ×1 | ||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| ABVX | $53.304.000 | 400.000 | 10,07% |
| ABVX | $27.226.884 | 204.314 | 5,15% |
| RARE | $20.034.000 | 600.000 | 3,79% |
| DFTX | $19.992.000 | 425.000 | 3,78% |
| SGMT | $15.691.382 | 2.029.933 | 2,97% |
| IFRX | $6.824.288 | 3.046.557 | 1,29% |
| Penerbit tidak dikenal (CUSIP: G50765109) | $5.680.000 | 500.000 | 1,07% |
| ALT | $5.293.345 | 1.741.232 | 1,00% |
| Penerbit tidak dikenal (CUSIP: G0375M101) | $5.080.000 | 500.000 | 0,96% |
| Penerbit tidak dikenal (CUSIP: 811292309) | $3.843.268 | 944.292 | 0,73% |
| ELVN | $3.552.500 | 70.000 | 0,67% |
| RNTX | $2.678.000 | 2.575.000 | 0,51% |
| DBVT | $2.573.258 | 156.906 | 0,49% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| VERA | Beli lebih banyak | +401K | +$17.8M |
| AMLX | Dipangkas | -1.1M | -$11.8M |
| NKTR | Dipangkas | -141K | -$10.6M |
| IMMX | Beli lebih banyak | +928K | +$10.0M |
| ORKA | Hanya pergerakan harga | +0 | +$8.5M |
| DRUG | Dipangkas | -110K | -$8.4M |
| MLTX | Beli lebih banyak | +356K | +$7.3M |
| ANNX | Beli lebih banyak | +1.0M | +$6.1M |
| ALMS | Hanya pergerakan harga | +0 | +$5.2M |
| CTNM | Beli lebih banyak | +121K | +$4.7M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| APGE | 30 Juni 2026 | 374.000 | $31.479.580 | 1,5% |
| IRON | 31 Maret 2026 | 250.000 | $19.852.500 | 26,5% |
| RAPT | 31 Maret 2026 | 581.187 | $19.684.804 | Tidak lagi dilacak |
| SLNO | 31 Maret 2026 | 400.000 | $18.520.000 | Tidak lagi dilacak |
| ASND | 31 Des. 2025 | 75.000 | $14.910.750 | 20,1% |
| DNTH | 31 Maret 2026 | 350.000 | $14.423.500 | 38,2% |
| KALV | 30 Juni 2026 | 675.000 | $13.587.750 | Tidak lagi dilacak |
| IMVT | 30 Juni 2026 | 545.625 | $13.553.325 | 16,7% |
| JBIO | 30 Juni 2026 | 964.462 | $13.550.691 | 4,4% |
| ABVX | 31 Des. 2025 | 150.000 | $12.735.000 | -11,0% |
| ZBIO | 30 Juni 2026 | 524.066 | $10.245.490 | 24,7% |
| VRDN | 30 Juni 2025 | 750.000 | $10.110.000 | 75,0% |
| MRUS | 30 Juni 2025 | 237.156 | $9.981.896 | Tidak lagi dilacak |
| FULC | 31 Maret 2026 | 800.000 | $9.048.000 | -48,8% |
| CYTK | 31 Des. 2025 | 150.000 | $8.244.000 | 20,7% |
| UPB | 31 Maret 2026 | 300.000 | $8.145.000 | -21,9% |
| XENE | 31 Des. 2025 | 200.000 | $8.030.000 | 42,7% |
| ASND | 30 Juni 2025 | 50.000 | $7.793.000 | 48,4% |
| DVAX | 30 Juni 2025 | 595.879 | $7.728.551 | Tidak lagi dilacak |
| AKBA | 30 Sep. 2025 | 1.985.915 | $7.228.731 | -67,9% |
| CMPX | 30 Juni 2026 | 1.350.000 | $7.141.500 | 13,5% |
| SCYX | 30 Juni 2026 | 7.554.347 | $6.926.581 | 29,6% |
| RARE | 31 Maret 2026 | 300.000 | $6.900.000 | 26,0% |
| JSPR | 31 Maret 2025 | 322.380 | $6.892.484 | -82,3% |
| EOLS | 30 Sep. 2025 | 720.118 | $6.632.287 | 36,1% |
| ACLX | 30 Sep. 2025 | 100.000 | $6.585.000 | Tidak lagi dilacak |
| CNTX | 30 Juni 2026 | 2.238.496 | $5.864.860 | -15,1% |
| UNCY | 30 Juni 2026 | 796.558 | $5.241.352 | 22,0% |
| TENX | 30 Juni 2026 | 327.307 | $5.233.639 | -88,1% |
| IONS | 31 Des. 2025 | 80.000 | $5.233.600 | -23,7% |
| DNTH | 30 Juni 2025 | 275.000 | $4.988.500 | 522,5% |
| AKRO | 31 Des. 2025 | 103.848 | $4.930.703 | Tidak lagi dilacak |
| TSHA | 31 Des. 2025 | 1.500.000 | $4.905.000 | 16,5% |
| SMMT | 30 Juni 2025 | 250.000 | $4.822.500 | -39,1% |
| ORKA | 31 Maret 2025 | 228.803 | $4.436.490 | 967,5% |
| PCVX | 30 Juni 2025 | 115.517 | $4.361.922 | 91,4% |
| AUTL | 30 Juni 2025 | 2.728.910 | $4.229.811 | 6,4% |
| DBVT | 31 Des. 2025 | 378.594 | $3.785.940 | -22,6% |
| LEGN | 31 Des. 2025 | 113.460 | $3.699.931 | 4,2% |
| KALV | 30 Sep. 2025 | 323.170 | $3.653.437 | Tidak lagi dilacak |
| BEAM | 30 Juni 2025 | 175.562 | $3.428.726 | 68,3% |
| CNTA | 30 Sep. 2025 | 225.000 | $2.956.500 | Tidak lagi dilacak |
| MREO | 30 Juni 2025 | 1.275.000 | $2.868.750 | -88,7% |
| SANA | 31 Maret 2026 | 700.000 | $2.849.000 | 38,0% |
| OPTN | 31 Maret 2025 | 370.269 | $2.473.397 | Tidak lagi dilacak |
| ABSI | 31 Des. 2025 | 796.438 | $2.421.172 | 176,6% |
| HRMY | 31 Des. 2025 | 85.000 | $2.342.600 | 4,8% |
| PHVS | 30 Juni 2026 | 82.800 | $2.339.100 | 4,5% |
| SRRK | 30 Sep. 2025 | 61.607 | $2.182.120 | 48,3% |
| VYGR | 30 Juni 2025 | 626.275 | $2.116.810 | 9,5% |
| URGN | 31 Maret 2025 | 187.843 | $2.000.528 | 347,8% |
| AVTX | 30 Juni 2026 | 124.666 | $1.861.263 | 11,0% |
| ALKS | 30 Juni 2026 | 50.000 | $1.768.000 | -3,3% |
| PMN | 30 Sep. 2025 | 2.645.128 | $1.279.713 | 3372,1% |
| PLRX | 31 Des. 2025 | 850.000 | $1.258.000 | -2,9% |
| CAPR | 31 Des. 2025 | 87.700 | $632.317 | -73,3% |
| HLXB | 30 Sep. 2025 | 29.381 | $312.026 | Tidak lagi dilacak |